The test – which Babylon says is being offered at cost and will use a kit developed by Abbott – can be taken at home but won’t give an immediate results as the sample needs to be sent for ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

Abbott Laboratories shares were down Wednesdsay morning after the company laid out guidance for the first quarter of the year ...

Abbott stock reversed early losses Wednesday on its strong sales outlook for 2025 and a bullish performance from its diabetes ...

The ABBOTT PRISM system is intended for in vitro diagnostic use only. A high throughput, highly automated test system for blood screening: The ABBOTT PRISM is a fully automated, high-volume blood ...

The clinical chemistry test is intended to help diagnose heart failure using the N-terminal pro b-type natriuretic peptide biomarker.

Abbott Laboratories ABT shares are trading at ... the company is consistently expanding its test menus and is also capitalizing on the growing demand for respiratory tests that can be performed ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.